Ibuprofen-13C, d3

CAT:
804-HY-78131S1
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Ibuprofen-13C, d3 - image 1

Ibuprofen-13C, d3

  • Description :

    Ibuprofen-13C, d3 is the 13C- and deuterium labeled Ibuprofen. Ibuprofen is an anti-inflammatory agent targeting COX-1 and COX-2 with IC50s of 13 μM and 370 μM, respectively[1].
  • Product Name Alternative :

    (±) -Ibuprofen-13C, d3
  • UNSPSC :

    12352005
  • Hazard Statement :

    H302
  • Target :

    Apoptosis; COX; Isotope-Labeled Compounds; Parasite
  • Type :

    Isotope-Labeled Compounds
  • Related Pathways :

    Anti-infection; Apoptosis; Immunology/Inflammation; Others
  • Applications :

    COVID-19-immunoregulation
  • Field of Research :

    Inflammation/Immunology; Cancer
  • Solubility :

    10 mM in DMSO
  • Smiles :

    OC(C(C1=CC=C(C=C1)CC(C)C)[13C]([2H])([2H])[2H])=O
  • Molecular Formula :

    C12 13CH15D3O2
  • Molecular Weight :

    210.29
  • Precautions :

    P264-P270-P330-P501
  • References & Citations :

    [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-223.|[2]Driban JB, et al. Joint inflammation and early degeneration induced by high-force reaching are attenuated by ibuprofen in an animal model of work-related musculoskeletal disorder. J Biomed Biotechnol. 2011;2011:691412|[3]Khwaja F, et al. Ibuprofen inhibits survival of bladder cancer cells by induced expression of the p75NTR tumor suppressor protein. Cancer Res. 2004 Sep 1;64 (17) :6207-13.|[4]Noreen Y, et al. Development of a radiochemical cyclooxygenase-1 and -2 in vitro assay for identification of natural products as inhibitors of prostaglandin biosynthesis. J Nat Prod. 1998 Jan;61 (1) :2-7.|[5]Palayoor ST, et al. Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen. Oncogene. 1999 Dec 2;18 (51) :7389-94.|[6]Rao GH, et al. Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin. Arteriosclerosis. 1983 Jul-Aug;3 (4) :383-8.
  • Shipping Conditions :

    Room temperature
  • Scientific Category :

    Isotope-Labeled Compounds
  • Clinical Information :

    No Development Reported
  • CAS Number :

    [1261394-40-4]

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide